Thursday, May 31, 2018

Indonesia Industrial Water and Waste Water Treatment Market Outlook Research Report : Ken Research


The report titled Indonesia Industrial Water and Waste Water Treatment Market Outlook to 2022 - by Region (Sumatra, Jakarta & Java, Sulawesi, Kalimantan, Maluku & Irian Java) and by Industry (Power, Seel, Palm Oil, Food & Beverages, Oil and Gas and Others) provides a comprehensive analysis on the Indonesia Industrial water and waste water treatment market. The report covers various aspects including introduction, ecosystem, EPC Market size by value of order intake, market segmentation by region (Sumatra, Jakarta & Java, Sulawesi, Kalimantan, Maluku & Irian Java), by Industry (Power, Steel, Palm Oil, Food & Beverages, Oil and Gas and Others), growth drivers, restraints, key regulations, future outlook and analyst recommendation.
This report will help the reader to identify the ongoing trends in the industry and anticipated growth in future depending upon changing industry dynamics in coming years. The report is useful for equipment manufacturers, water treatment consumable manufacturers and suppliers, environmental associations, EPC companies and potential entrants and other stakeholders to align their market centric strategies according to ongoing and expected trends in the future.
Market Size
Industrial water and waste water treatment industry in Indonesia registered a positive five year CAGR during 2012-2017. The market size by order intake has increased constantly from 2012 to 2017. The growth was mainly driven by strict implementation of regulatory norms and increased government incentives to bring economic reforms to Indonesia and start its transformation from a service-based economy to a manufacturing-based economy. This has led to an increased demand for energy and a rise in manufacturing industries which in turn has promoted the development of water treatment industry.
Market Segmentation
By Region: Sulawesi was the biggest market for water treatment industries in 2017. Large cocoa plantations, power plant and infrastructure projects were the key drivers for this growth. Java and Jakarta was the second largest contributors followed by Sumatra especially after its discovery as a destination with geothermal potential. Kalimantan and Maluku had the lowest share due to poor implementation and low industrial penetration.
By Industry: Thermal power plants were the largest users of water treatment facilities in Indonesia. It was followed by Palm Oil Industry. Indonesia is a leader in the global exports for palm oil and is the largest producer in the world. Iron and steel industry was the third in market share due to rising demand for steel consumption in various infrastructure projects that has increased the demand for water treatment in this industry. Indonesia has also emerged as a hub for manufacturing Food & Beverages due to rising investments and rise in user penetration for packaged food products. Pharmaceuticals, Textile, tannery, oil and gas, automobile, electronics are some other key sectors where there is demand of water treatment.
Restraints
Poor implementation of existing regulations in many parts of the country, lack of WWTPs in SMEs, fragmented market in equipment supply, poor energy efficiency among the waste water treatment facilities, lack of funds, price sensitivity in tenders, and poor investment in R&D are some key restraints in the water treatment business.
Growth Drivers
Stringent regulations, depleting water resources and degrading water quality, rising industrialization, government initiatives for cleaning up polluted rivers, companies opting for zero liquid discharge through their units and huge untapped market potential due to urbanization and low penetration of water treatment equipments are the key growth drivers in the Indonesia Industrial water and waste water treatment market
Future Outlook
It is expected that market will register constant growth registering increasing value of order intake. Demand is expected to be highest in Sulawesi followed by the Java & Jakarta. Cities along river coasts are expected to emerge as new hubs with highest growth potential. Demand is expected to rise in ZLD segment as strict regulations regarding water discharge and conservation comes into play. Significant drop is expected in coal based power plants due to increased use of renewable energy and gas based plants.
For more information on the research report, refer to below link:
Related Reports
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
sales@kenresearch.com
+91-9015378249



Wednesday, May 30, 2018

Indonesia Healthcare Market: Ken Research

What is the Potential of Indonesia Healthcare Market?
The Indonesia Healthcare Market has shown a positive incline during 2012-2017 but with respect to the expanding population of Indonesia, the market is still underserved especially in the underdeveloped and rural areas as of 2017. People across Indonesia are facing several health care issues due to sedentary lifestyle and fast food consumption habits, such as obesity, diabetes, and other cardiovascular diseases, which are demanding for technologically advanced healthcare infrastructure. The healthcare market has increased on the account of increasing healthcare facilities, innovation in pharmaceutical manufacturers and clinical laboratory services and expansion of pharmacy retail chains across the country. The market has witnessed enhancing innovation in nutritional health segment, biopharmaceuticals and specialty pharmaceutical products.

Hospitals in the country contributed to the maximum share of overall healthcare market as of 2016. Over ~% of the market revenues were generated from the hospitals segment followed by the pharmaceutical market with ~% in 2017.

The Indonesia Healthcare market revenue has increased from USD ~ billion in 2012 to USD ~ billion in 2017 primarily due to rising prevalence of non-communicable and lifestyle diseases including diabetes, asthma and heart disorders. The industry has undergone various deregulation programs which has encouraged foreign investment in the industry. Furthermore, increase in demand for generic medicines has led the major players in the industry to expand their production capabilities.

How Has the JKN Scheme Impacted the Indonesia Pharmaceutical Market?
The market size of Indonesia pharmaceutical industry has increased from USD ~ million in 2012 to USD ~ million in 2017 at a CAGR of ~%. The market is in the growing stage supported by favorable government regulations and entry of foreign players in the space. During 2017, the domestic players dominate the market with major focus on production of generic drugs. This is driven by the implementation of universal healthcare system. The program has led to an increased demand for generic medicines from public and private hospitals participating in the program. Further, the industry witnessed various deregulation programs which encouraged foreign investment in the industry. For instance, the government removed the pharmaceutical industry from its negative investment list implying 100% foreign ownership is allowed. Major therapeutic segments was anti-infective due to the prevalence of communicable diseases such as TB, influenza and others followed by Gastrointestinal, cardiovascular, Central nervous system, respiratory, musculoskeletal and dermatology.

How Have the Various Segments Performed in Indonesia Pharmaceutical Market?
Anti-infective drug sale has contributed to the largest share of ~% in the revenue share of Indonesia Pharmaceutical industry in 2017. This is mainly due to high prevalence of bacterial and communicable diseases. This is followed by Gastrointestinal and metabolism drugs with ~%, cardiovascular system drugs with ~%, Central Nervous system drugs with ~%, and Respiratory system drugs with ~%. The domestic players have accounted for ~% of the revenue in Indonesia pharmaceutical market. International players have captured ~% of the revenue share in 2017 driven by favorable government regulation. Generic drugs have accounted for the major share of ~% of the revenue share in 2017. The share of patented drugs has increased from ~% in 2013 to ~% in 2017.

How is the Competitive Ladscape of Indonesia Pharmaceutical Market?
There are ~ pharmaceutical companies (~ domestic and ~ international companies) located in Indonesia and ~% of them are located in Java in 2016. These players compete on the basis of distribution network, product portfolio, marketing activities and research and development. The domestic players dominate the generic drug and OTC drug segment.

How is the Indonesia Pharmacy Retail Market Growing?
Indonesia pharmacy retail sector is in the mid to late growth stage with the presence of over ~ drugstores and pharmacies along with revenue CAGR of ~% in the last five years. Already established players such Guardian Pharmacy, Kimia Farma, Apotek K-24 have increased their number of pharmacy retail outlets over the period 2012-2017. The number of pharmacies operated by Guardian pharmacy increased from ~ in 2013 to ~ in 2016 whereas for Kimia Farma, the number of pharmacies increased from ~ in 2013 to ~ in 2016. Over 2012-2017, the number of pharmacies has inclined at a CAGR of ~%. Increasing incidence of life-style related ailments such as Diabetes, Obesity, hypertension and various heart related diseases and prevalence of communicable diseases such as TB, influenza among the growing population are the main reasons behind positive growth in pharmacy retail revenue due to growth in private label goods.

How Have the Various Segments Performed in Indonesia Pharmacy Retail Market?
Pharmacies have accounted for ~% of the share of Indonesia pharmacy retail revenue in 2017 whereas drugstores have accounted for ~% of the revenue share. The number of pharmacies increased from ~ in 2012 to ~ in 2017 with average revenue of a pharmacy estimated at IDR ~billion in 2017. The number of drugstores increased from ~ in 2012 to ~ in 2017. West Java has gathered ~% of the total pharmacies and drugstores in Indonesia in 2015. This can be attributed to more number of hospitals located in the region. East Java has captured ~% of the pharmacies and drugstores driven by increase in foreign investment in the pharmacy sector.

What are the Major Companies Operating in This Space?
The pharmacy retail market in Indonesia is highly fragmented with major organized chains (Guardian pharmacy, Kimia Farma, Apotek K-24 and AS Watsons Group) accounting for ~% of the revenue share in 2016. These players compete on parameters such as proximity, value added services, availability of drugs, promotional offers and tie ups with major healthcare institutions. In order to increase their revenue, the players offer their products through online portals.

What Factors have driven Indonesia Clinical Laboratory Market?
Indonesia Clinical Laboratory Market is in the growing stage. The market has grown at a CAGR of ~% during 2012 to 2017 with revenue estimated at USD ~ billion in 2017. The industry has witnessed expansion of private laboratory chains and use of advanced technology in order to provide high quality laboratory services. With the implementation of JKN, the demand for laboratory services has further increased. The public hospitals mostly perform routine test while the esoteric tests are outsourced to the private clinical laboratories.  Due to growing awareness amongst people about healthy living, private and public laboratories have witnessed an increase in walk in patients asking for routine checkups which is funded out of the patient’s pocket. Further, the major private laboratory chains have expanded their operations in terms of capacity and geographic presence. The six major private laboratories occupying ~% of the revenue share of Indonesia Private independent labs in 2016 are Prodia, Kimia Farma, Pramita, Cito, Parahita and BioMedika.

What are the Major Market Segments in Indonesia Clinical Laboratory Market?
The public clinical labs have accounted for ~% of the revenue share in Indonesia clinical laboratory market in 2017. Private hospital labs have accounted for ~% in 2017 and private independent labs with ~% of the overall market. The laboratory chains have been the leading market players in Indonesia in 2016 with ~% of revenue in the overall private independent laboratory market in 2016. Single independent labs have contributed to their lower revenue share of ~% due to their restricted geographic presence.

What Are the Major Competition Parameters?
The private independent clinical laboratory market is organized and is composed of both chain laboratories and stand-alone laboratories. The chain laboratories are the leading market players in Indonesia. The 6 major players in the industry are Prodia, Kimia Farma, Pramita, Cito, BioMedika and Parahita which together accounted for ~% of the revenue share in private independent laboratory market in 2017.

How has Indonesia Medical Device Market Grown?
The market was in the growing stage during 2012-2017 and is almost entirely import driven. The market has seen increasing number of foreign players supported by growing number of hospitals or other health centers in Indonesia. There were ~ medical device distributors and ~ medical device production units in Indonesia as of 2015. Indonesian export performance for medical equipment commodity also exhibited a positive trend. The main export destination for Indonesian medical equipment are Singapore, Germany, Japan, the United States, China, the Netherlands, India, Malaysia, Myanmar and Afghanistan. The demand has increased majorly for diagnostic imaging, medical consumables, aesthetic, orthopedic and dental products. This is driven by increased healthcare spending and rising awareness about different treatment methods. Rising share of esoteric tests has created demand for modern equipment such as pacemakers with micro-chip technology, laser surgical device and test kits, which may include monoclonal antibody technology.

How have the Different Segments in Indonesia Medical Device Market Performed?
Diagnostic imaging products have accounted for the largest share of ~% of the revenue share in Indonesia Medical Devices market in 2017. This is followed by medical consumable product with ~%, aesthetic devices with ~%, auxiliary devices with ~%, dental products with ~% and orthopedic implants with ~%. Hospitals both public and private are the major end users of medical devices and have accounted for ~% of the revenue in Indonesia Medical devices market in 2017. The medical clinics and Laboratories and other healthcare institutions together have contributed ~% of the revenue.

What are the Major Companies Operating in the Space?
The major local manufacturers include Indo Health Medical, PT Andini Sarana, PT Trimitra Garmedindo Interbuana, PT Mega Andalan Kalasan and Citra Medika Lestari. The major international players include GE Healthcare, Siemens, Philips, Samsung and Hitachi. Major distributors include PT Mensa Bina Sukses, PT Transmedic Indonesia and PT Surgika Alkesindo.

How has Indonesia Hospital Market Grown?
The hospital market grew at a five year CAGR of ~% during 2012-2017 from USD ~ billion in 2012 to USD ~ billion in 2017. Major driving factor for increase in hospital market was the prevalence of the severe chronic diseases in Indonesia. Several diseases like Pneumonia, Multi-bacillary (MB) Leprosy and Diarrhea had increased in the year 2015. The number of specialty hospitals increased from ~ in 2012 to ~ in 2017. The industry is still in the nascent stage with huge scope for development. The market has witnessed rise in use of digital healthcare services. For instance, Practo entered the Indonesian market in 2015 providing consumers the option of searching for doctors through a database of over 4,200 doctors, and covering 60% of the clinics in Jakarta DKI. Further, the market revenue growth was facilitated by increase in the allocation of the Government budget from IDR ~ Trillion in 2012 to IDR ~ Trillion in 2017. The foreign investments rose from USD ~ million in the year 2015 to USD ~ million in the year 2016.

How have the Major Segments in Indonesia Hospital Market Performed?
Public hospitals have accounted for ~% of the number of hospitals. Private hospitals have registered ~% of the total hospitals in Indonesia in 2016 as the demand for modern medicine and specialist services increased in the country. General hospitals have accounted for ~% of the total number of hospitals whereas specialty hospitals which include hospitals such as mental hospital, leprosy hospital, eye hospital and others have registered ~% of the total number of hospitals. Mother and children has accounted for ~% of the number of specialty hospitals in 2015 followed by maternity hospitals with ~% and mental hospital with ~% of the share in 2015. Rest of the market includes Eye hospital, leprosy hospital and pulmonary tuberculosis hospital with ~%, ~% and ~% respectively of the total number of specialty hospitals in 2015. East Java has gathered ~% of the number of beds in Indonesia in 2016

Major hospitals include Siloam Hospital group, Hermina Hospital Group, Rumah Sakit Mitra, Awal Bros Hospital Group, Sari Asih Group, Ramsay Sime Darby Healthcare and Eka Hospital group. Major competition parameters for private hospitals are facilities, number of beds, number of hospitals, fees, quality of doctors/medical practioners and specialization

For more information on the research report, refer to below link:

Related Reports by Ken Research



Contact:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204

India Dyes Market is expected to Reach around INR 48,000 Crore by the Year Ending 2022: Ken Research

India Dyes Market by Market Structure (Unorganized and Organized Market), by Product Type (Reactive Dyes, Disperse Dyes, Direct Dyes, Acid Dyes, VAT Dyes and Others), by Application (Textiles, Leather, Paper, Printing Inks and Others), by Export and Domestic Sales; Company Profile of Major Players (Bodal Chemicals, Clariant Chemicals, Atul Chemicals, Aksharchem Ltd, Kiri Industries, Colourtex Industries and Jay Chemicals)
The dye and dye intermediaries market in India is expected to achieve a target of more than INR 40,000 crore by the end of this decade (2020).
The US and European chemical manufacturers are witnessed to shift their manufacturing and production bases to low-cost countries including India thus boosting the domestic manufacturing.
Growing infrastructural development coupled with rapid industrialization is further anticipated to drive the demand for dyes used during construction activities in India.
Analysts at Ken Research in their latest publication “India Dyes Market Outlook to 2022 – By Market Structure (Organized and Unorganized Market), By Product Type (Reactive, Disperse, Direct, Acid, VAT and Others), By Applications (Textiles, Leather, Printing Inks, Paper and Others) and By Export and Domestic Sales” believe that reducing dependency on textiles, investing towards reducing adverse environmental effect, opting for backward integration model to expand business operations, expansion through mergers and acquisitions, extending product / business portfolio and focusing towards eco-friendly dyes will create a positive impact on the market. India dyes market is expected to register a positive CAGR of more than 7% during the forecast period 2017-2022E. The market is further expected to be driven by shutdown of chemical manufacturers in China, thereby affecting the dyes production on a larger scale. As a result, it has boosted the demand for Indian products across the globe and will continue to do the same over long term.
India dyes market is poised to grow on account of end-user demand including textiles, leather, printing inks, paper, plastics, foods and beverages, construction, automotives and others. Leading chemical companies in India have started to invest towards expanding their operational capacity in order to meet the ever-growing domestic as well as export demand for dyes. They have started to fit in the use of natural substances such as organic azo dyes owing to its friendly nature towards environment, thus assuring safe usage. Along with increasing competition between MNC’s and domestic firms in India, the dyes market is further expected to witness more strategic alliances and joint ventures/acquisitions in near future.
Trending consumer choices along with ever-changing fashion industry in India are further expected to drive the sales of reactive and disperse dyes towards the country’s textile industry.
Key Topics Covered in the Report
Trends India Dyes
Global Dyes Market
Dyes Imports to India
Dyes Manufacturers in India
Dyestuff Production in India
Production Capacity Dyestuff
Pricing Analysis in India Dyes Market
Dyes Exports from India
Demand for Dyes in India
India Direct Dyes Industry
Dyes Production India
Dyes Market in India
India Dyes Industry
Indian Reactive Dyes Market
Reactive Dyes and Disperse Dyes
Dye End-User Applications in India
India VAT Dyes Market
Dyes Sales Volume India
India Disperse Dye Market
For More Information, Refer to the Link below

Related Reports:
Contact Us:
Ken Research 
Ankur Gupta, Head Marketing & Communications
+91-9015378249

UAE Fitness Services Market is Driven By Health Conscious Population under the Age Bracket 15-64 years and Growing Penetration of Organised Fitness Service Centres: Ken Research Analysis


Rise in the number of additional services, Inclining Number of organised fitness centres and Introduction of new fitness centres will be the key factors driving growth in UAE Fitness Services Market.

The UAE Fitness Services market has surged with rising number of fitness centres. Organised fitness centres have approximately nine major players which account around 90 fitness service outlets in UAE. Number of fitness service centres has been expected to increase at a CAGR of 6.7 during the period 2018 - 2022. Rise in services offered by fitness centres such as swimming pool, in house juice bar, sports facility and many others have attracted the customers towards the organised fitness service centres. Organised fitness services market represents the maximum potential to grow in future as there is shift in behaviour of people due to increase in awareness regarding physical health fitness.

One of the major reasons behind surging growth of the unorganised fitness centres is the low membership fees and easy accessibility of fitness centres from a customer’s house as they are majorly present in the housing locality only. People who are still looking forward to built their body into a muscular one usually focus towards unorganised fitness centres as these centres generally provides hardcore weight training to its customers.

Increase in group exercise such as Zumba, Pilates, cross fit, Martial Arts, Power Yoga is also contributing to the growth of the fitness service market as in future majority of the new fitness centres will be looking forward to offer these services at lower rates to capture majority of the customers into their fitness centres. Currently, these group exercises has been majorly offered in organised fitness centres only but in future it has been expected various new unorganised fitness centres will also provide facility of group exercise to their customers to remain into the competition of the market.

For more information on the research report, refer to below link:

The Dietary and Supplement Market Is Dominated By Standard Supplements including Vitamins, Irons, Calcium, Essential Enzymes and Others In Saudi Arabia

Many of the branches of Gold's Gym, Celebrity Fitness and Fitness First work on the Franchise Model

Brazil is the second largest fitness industry in the world and in long run personalized training programs, online or offline will be more preferred.

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249

Indonesia Pharmaceutical Market Research Report to 2022: Ken Research

What is the Potential of Indonesia Healthcare Market?
Indonesia Healthcare Market has shown a positive incline during 2012-2017 but with respect to the expanding population of Indonesia, the market is still underserved especially in the underdeveloped and rural areas as of 2017. People across Indonesia are facing several health care issues due to sedentary lifestyle and fast food consumption habits, such as obesity, diabetes, and other cardiovascular diseases, which are demanding for technologically advanced healthcare infrastructure. The healthcare market has increased on the account of increasing healthcare facilities, innovation in pharmaceutical manufacturers and clinical laboratory services and expansion of pharmacy retail chains across the country. The market has witnessed innovation in nutritional health segment, biopharmaceuticals and specialty pharmaceutical products.

Hospitals in the country contributed to the maximum share of overall healthcare market as of 2016. Over ~% of the market revenues were generated from the hospitals segment followed by the pharmaceutical market with ~% in 2017.

Indonesia Healthcare market revenue has increased from USD ~ billion in 2012 to USD ~ billion in 2017 primarily due to rising prevalence of non-communicable and lifestyle diseases including diabetes, asthma and heart disorders. The industry has undergone various deregulation programs which has encouraged foreign investment in the industry. Furthermore, increase in demand for generic medicines has led the major players in the industry to expand their production capabilities.

How Has the JKN Scheme Impacted the Indonesia Pharmaceutical Market?
The market size of Indonesia pharmaceutical industry has increased from USD ~ million in 2012 to USD ~ million in 2017 at a CAGR of ~%. The market is in the growing stage supported by favorable government regulations and entry of foreign players in the space.

During 2017, the domestic players dominate the market with major focus on production of generic drugs. This is driven by the implementation of universal healthcare system. The program has led to an increased demand for generic medicines from public and private hospitals participating in the program.

Further, the industry witnessed various deregulation programs which encouraged foreign investment in the industry. For instance, the government removed the pharmaceutical industry from its negative investment list implying 100% foreign ownership is allowed. Major therapeutic segments was anti-infective due to the prevalence of communicable diseases such as TB, influenza and others followed by Gastrointestinal, cardiovascular, Central nervous system, respiratory, musculoskeletal and dermatology.

How Have the Various Segments Performed in Indonesia Pharmaceutical Market?
Anti-infective drug sale has contributed to the largest share of ~% in the revenue share of Indonesia Pharmaceutical industry in 2017. This is mainly due to high prevalence of bacterial and communicable diseases. This segment is dominated by prescription drugs since the patients infected with bacterial and viral diseases need to consult a doctor for proper treatment of the particular disease. This is followed by Gastrointestinal and metabolism drugs with ~%, cardiovascular system drugs with ~%, Central Nervous system drugs with ~%, Respiratory system drugs with ~%, Musculoskeletal system drugs with ~%, dermatology drugs with ~%, genitourinary and hormonal drugs with ~%, blood related drugs with ~%, oncology with ~% and rest of the therapeutic segments with ~% of the revenue share in 2017.

Domestic players have accounted for ~% of the revenue in Indonesia pharmaceutical market in 2017 driven by the implementation of JKN (National Health Insurance System) in 2014. The product portfolio of majority domestic pharmaceutical companies is dominated by generic drugs. International players have captured ~% of the revenue share in 2017 driven by favorable government norms for foreign ownership.

How Major Segments in Indonesia Pharmaceutical Market have performed?
Generic drugs have accounted for the major revenue share of ~% in 2017 driven by the increased demand from government run hospitals and clinics. The share of patented drugs has increased from ~% in 2013 to ~% in 2017. Further, ethical generic drugs have accounted for ~% of the Indonesia generic drug market revenue in 2017 followed by free sale drugs with ~% and unbranded drug sale with ~%. The Prescription drugs sales have accounted for ~% of the revenue share in Indonesia Pharmaceuticals Market. OTC drugs have accounted for ~% of the revenue share in 2017 as more number of people took to self medication. Domestic sales have accounted for a majority revenue share of ~% in 2017 whereas exports have accounted for a small share of ~%. The domestic market is dominated by the sale of low priced ethical generic medicines. West java has accounted for ~% of the pharmaceutical companies in 2016. This is followed by Jakarta with ~%, East java with ~%, Central Java with ~% and others with ~% of the companies

What are the major Trends and growth Drivers in Indonesia Pharmaceutical Market?
Growth in animal pharmaceutical has added to the overall market revenue. The animal pharmaceuticals industry has benefitted from opportunities in terms of new legislations for animal pharmaceuticals. With the launch of 11th economic package, the government has aimed to boost the domestic production of medicines' raw materials. Moreover, the government has removed the pharmaceutical industry from its negative investment list (which lists the sectors that are closed, or partially closed, for foreign ownership) implying 100% foreign ownership is allowed. The policy also encourages joint ventures between foreign pharmaceutical companies and local ones in order to transfer knowledge and technology. In addition to this, the government is planning to offer fiscal incentives and making the investment procedure easier to attract foreign players in the industry. 

The Universal healthcare system launched by the government in 2014 has led to an increase in the production of generic medicines. This has led to lowering margins as people have shifted from ethical drugs to prescribed generic drugs but at the same time the sales volume has increased. The market has witnessed rising number of mergers and acquisitions as a part of expansion strategy by major domestic and international players.

How is the Competitive Ladscape of Indonesia Pharmaceutical Market?
There are ~ pharmaceutical companies (~ domestic and~ international companies) located in Indonesia and ~% of them are located in Java in 2016. These players compete on the basis of distribution network, product portfolio, marketing activities and research and development. The domestic players dominate the generic drug and OTC drug segment. The domestic players dominate the generic drug and over the counter drug segment. International players have better expertise, skilled labor and infrastructure to produce such medicines at competitive prices.

What is the Future Potential of Indonesia Pharmaceutical Market?
The Indonesia pharmaceutical industry is expected to increase from USD ~ billion in 2018 to USD ~ billion at a growth rate of ~%. The industry growth will be led by Indonesia’s large population and growing middle-income class, supportive government policies and higher investment in the industry. With the increase in incidence of communicable diseases such as HIV, TB, therapeutic segments such as anti infectives and respiratory are expected to grow. Major companies are expected to increase investment in nutritional and herbal medicines due to changing preference in the industry. Apart from manufacturing generic and patented drugs, pharmaceutical companies will shift focus to other niche segments such as combined dosages, novel drug delivery areas. Further in order to overcome the shortcomings, Contract Development and Manufacturing Organizations (CDMOs) will emerge as an attractive resource for manufacturers seeking to expand their capacities

For more information on the research report, refer to below link:

Related Reports by Ken Research



Contact:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204